About

Peter R. Carroll is a world-renowned urologic oncologist whose research has fundamentally shaped the modern surgical management of prostate cancer. His key contributions center on advancing robot-assisted radical prostatectomy (RARP), systematically evaluating its outcomes against traditional open surgery. Carroll led landmark meta-analyses—one on urinary continence recovery (1,294 citations) and another on oncologic outcomes (518 citations)—that provided the highest-level evidence for RARP’s safety and efficacy. He also chaired the Pasadena Consensus Panel, establishing best practices for RARP that are now standard worldwide (310 citations). His work extends to high-risk disease, with studies on neoadjuvant therapy (62 citations) and comparative effectiveness in community settings (60 citations), demonstrating that surgical expertise matters as much as technique. Carroll’s research has been cited over 2,500 times, reflecting its profound impact on clinical guidelines and patient care. As a professor at UCSF and former chair of urology, he has trained generations of surgeons and continues to shape the field through rigorous evidence synthesis and advocacy for quality outcomes.

Research Focus

Key Achievements

14
H-Index
17
Papers
2,716
Total Citations
160
Avg Citations/Paper
🏆 Most Cited Paper
Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy
1,294 citations · 2012
📈 Most Prolific Year: 2012 (4 Papers)
🤝 Key Collaborators: 72
🏛 Institutions: University of California, San Francisco, The University of Texas at San Antonio Health Science Center, UCSF Helen Diller Family Comprehensive Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago